
    
      The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been
      renamed to Bayer Schering Pharma AG (BSP AG), Germany.

      Bayer Schering Pharma AG, Germany is the sponsor of the trial.

      The previously posted secondary Outcome Measure "Parameters of safety and tolerability" has
      been removed from result posting as it is covered by the Adverse Event section.
    
  